| __timestamp | AstraZeneca PLC | Supernus Pharmaceuticals, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 26095000000 | 122045000 |
| Thursday, January 1, 2015 | 24708000000 | 144427000 |
| Friday, January 1, 2016 | 23002000000 | 215003000 |
| Sunday, January 1, 2017 | 22465000000 | 302238000 |
| Monday, January 1, 2018 | 22090000000 | 408897000 |
| Tuesday, January 1, 2019 | 24384000000 | 392755000 |
| Wednesday, January 1, 2020 | 26617000000 | 520397000 |
| Friday, January 1, 2021 | 37417000000 | 579775000 |
| Saturday, January 1, 2022 | 44351000000 | 667238000 |
| Sunday, January 1, 2023 | 45811000000 | 607521000 |
| Monday, January 1, 2024 | 54073000000 |
Igniting the spark of knowledge
In the ever-evolving pharmaceutical industry, revenue growth is a key indicator of a company's success and market position. Over the past decade, AstraZeneca PLC and Supernus Pharmaceuticals, Inc. have demonstrated contrasting revenue trajectories. AstraZeneca, a global leader, has seen its annual revenue soar by approximately 75% from 2014 to 2023, reaching a peak of $45.8 billion in 2023. This growth underscores AstraZeneca's strategic advancements and robust product pipeline.
Conversely, Supernus Pharmaceuticals, a smaller player, has experienced a more modest yet steady growth, with its revenue increasing by over 400% during the same period. Despite its smaller scale, Supernus's focus on niche markets has allowed it to carve out a significant presence, with revenues peaking at $667 million in 2022. This comparison highlights the diverse strategies and market dynamics within the pharmaceutical sector.
Breaking Down Revenue Trends: Eli Lilly and Company vs Supernus Pharmaceuticals, Inc.
Annual Revenue Comparison: AstraZeneca PLC vs Sanofi
AstraZeneca PLC or Biogen Inc.: Who Leads in Yearly Revenue?
Comparing Revenue Performance: AstraZeneca PLC or United Therapeutics Corporation?
AstraZeneca PLC and Incyte Corporation: A Comprehensive Revenue Analysis
Revenue Showdown: AstraZeneca PLC vs Jazz Pharmaceuticals plc
AstraZeneca PLC vs Pharming Group N.V.: Examining Key Revenue Metrics
AstraZeneca PLC and Ligand Pharmaceuticals Incorporated: A Comprehensive Revenue Analysis
SG&A Efficiency Analysis: Comparing AstraZeneca PLC and Supernus Pharmaceuticals, Inc.
Ligand Pharmaceuticals Incorporated vs Supernus Pharmaceuticals, Inc.: Examining Key Revenue Metrics
Revenue Insights: Supernus Pharmaceuticals, Inc. and Dynavax Technologies Corporation Performance Compared
Revenue Insights: Supernus Pharmaceuticals, Inc. and Taro Pharmaceutical Industries Ltd. Performance Compared